Skip to main content
Clinical Trials/NCT00162747
NCT00162747
Completed
Phase 4

Topical Emollient Therapy for Prevention of Infections in Preterm Infants

Johns Hopkins Bloomberg School of Public Health1 site in 1 country600 target enrollmentDecember 2001

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Skin Diseases
Sponsor
Johns Hopkins Bloomberg School of Public Health
Enrollment
600
Locations
1
Primary Endpoint
Three weeks after application of the intervention, blood will be drawn from those enrolled in the control group.
Status
Completed
Last Updated
20 years ago

Overview

Brief Summary

The purpose of this study is to determine how to best take care of the skin of preterm infants in order to prevent infections through the skin.

Detailed Description

The skin of babies who are born too early is not mature, which means they are at risk for infections of the skin or in the body. Their skin also become very dry, leading to cracking and breakdown, and this may feel painful or uncomfortable for the infant.

Registry
clinicaltrials.gov
Start Date
December 2001
End Date
June 2005
Last Updated
20 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Preterm infants

Exclusion Criteria

  • Full-term infant

Outcomes

Primary Outcomes

Three weeks after application of the intervention, blood will be drawn from those enrolled in the control group.

Secondary Outcomes

  • Atleast four additional times over the first four weeks of the child's life, the skin will be studied by lightly rubbing the skin with a cotton swab to detect germs on the skin and observing and recording the condition of the baby's skin.

Study Sites (1)

Loading locations...

Similar Trials